Morgan Stanley’s Guardian Pharmacy Services GRDN Stock Holding History

Morgan Stanley’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.1M	Buy	312,004 +195,036	+167%	+$7.55M	﹤0.01%	3480
2026 Q1	$4.41M	Sell	116,968 -29,283	-20%	-$957K	﹤0.01%	4233
2025 Q4	$4.4M	Sell	146,251 -12,624	-8%	-$357K	﹤0.01%	4276
2025 Q3	$4.17M	Buy	158,875 +125,908	+382%	+$3M	﹤0.01%	4292
2025 Q2	$703K	Buy	32,967 +16,947	+106%	+$382K	﹤0.01%	5287
2025 Q1	$341K	Sell	16,020 -6,411	-29%	-$132K	﹤0.01%	5511
2024 Q4	$454K	Buy	22,431 +22,055	+5,866%	+$455K	﹤0.01%	5460
2024 Q3	$6.32K	Buy	+376	New	+$6.34K	﹤0.01%	6845

Other funds holding GRDN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

VCM

Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Morgan Stanley's GRDN Position: Q2 2026 in Review

Morgan Stanley increased its Guardian Pharmacy Services (GRDN) stake by 167% in Q2 2026, buying an estimated $7.55M and bringing the position to 312,004 shares worth $13.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3480.

Morgan Stanley first reported a position in GRDN in Q3 2024 and has held it in 8 quarters since. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

Morgan Stanley held 312,004 shares of Guardian Pharmacy Services worth $13.1M as of Q2 2026.
Morgan Stanley bought 195,036 Guardian Pharmacy Services shares in Q2 2026, an estimated $7.55M.
Guardian Pharmacy Services made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #3480 holding.
Morgan Stanley first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 8 quarters since.
190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.